PROVIDER PROFILE · NPI 1720044811

John RiveraM.D.

Family PracticeMilldale, CTI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

515

Unique beneficiaries

—

Total services

698

Distinct HCPCS

Medicare payment

$59K

Peer benchmark

Total Medicare services vs. 532 Family Practice providers in CT — above median (cohort median 538).

PRESCRIBING · PART D · 2024

Total Rx claims

6,379

Beneficiaries

—

Total drug cost

$814K

Distinct drugs

112

Brand share

22.0%

Top prescribed drugs

Atorvastatin Calcium546 claims

Rosuvastatin Calcium523 claims

Amlodipine Besylate319 claims

Lisinopril270 claims

Levothyroxine Sodium244 claims

QUALITY · MIPS · 2024

Final MIPS score

83.4

Quality

73.9

Cost

79.6

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.36%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$2K

Education$15

Top paying entities

Food and Beverage$2K

Education$15

REFERRAL NETWORK

Where John Rivera's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Quest Diagnostics Llc Clinical Laboratory · Wallingford, CT	58	126
THE HOSPITAL OF CENTRAL CONNECTICUT AT NEW BRITAIN GENERAL AND BRADLEY	43	138
Monika Fuller Physician Assistant · East Haven, CT	23	46
MIDSTATE MEDICAL CENTER	13	25

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history